tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

STRO Stock Latest News

Sutro Biopharma: Transition to STRO-004–Driven Clinical Execution Warrants Hold as Long-Term Upside Meets Near-Term Uncertainty
RatingsSutro Biopharma: Transition to STRO-004–Driven Clinical Execution Warrants Hold as Long-Term Upside Meets Near-Term Uncertainty
4d ago
STRO
Sutro Biopharma Regains Nasdaq Listing Compliance
PremiumCompany Announcements
Sutro Biopharma Regains Nasdaq Listing Compliance
9d ago
8K
STRO
Sutro Biopharma regains compliance with Nasdaq
PremiumThe Fly
Sutro Biopharma regains compliance with Nasdaq
9d ago
STRO
Sutro Biopharma price target raised to $51 from $5 at Deutsche Bank
PremiumThe Fly
Sutro Biopharma price target raised to $51 from $5 at Deutsche Bank
9d ago
STRO
Sutro Biopharma’s Promising Phase 1 Study on STRO-004: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Sutro Biopharma’s Promising Phase 1 Study on STRO-004: A Potential Game-Changer in Cancer Treatment
12d ago
STRO
Vanguard Total Stock Market ETF (VTI) Daily Update—12/04/25
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Update—12/04/25
22d ago
HTZ
VTI
Sutro Biopharma Announces Reverse Stock Split
Premium
Company Announcements
Sutro Biopharma Announces Reverse Stock Split
23d ago
8K
STRO
Sutro Biopharma announces first cohort dosed in Phase 1 trial of STRO-004
Premium
The Fly
Sutro Biopharma announces first cohort dosed in Phase 1 trial of STRO-004
23d ago
STRO
Sutro Biopharma trading halted, news pending
PremiumThe Fly
Sutro Biopharma trading halted, news pending
24d ago
STRO
Sutro Biopharma announces 1-for-10 reverse stock split
PremiumThe Fly
Sutro Biopharma announces 1-for-10 reverse stock split
25d ago
STRO
Sutro Biopharma: Balancing Innovation with Caution Amid Strategic and Clinical Uncertainties
PremiumRatings
Sutro Biopharma: Balancing Innovation with Caution Amid Strategic and Clinical Uncertainties
1M ago
STRO
Sutro Biopharma: Sell Rating Amid Preclinical Data and Uncertain Clinical Prospects
PremiumRatings
Sutro Biopharma: Sell Rating Amid Preclinical Data and Uncertain Clinical Prospects
1M ago
STRO
Sutro Biopharma Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsSutro Biopharma Reports Q3 2025 Financial Results
2M ago
STRO
Sutro Biopharma Announces Major Organizational Restructuring
Premium
Company Announcements
Sutro Biopharma Announces Major Organizational Restructuring
3M ago
8K
STRO
Sutro Biopharma announces restructuring, workforce reduction of about 33%
Premium
The Fly
Sutro Biopharma announces restructuring, workforce reduction of about 33%
3M ago
STRO
Sutro Biopharma price target lowered to $4 from $7 at Jefferies
PremiumThe Fly
Sutro Biopharma price target lowered to $4 from $7 at Jefferies
4M ago
STRO
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers
PremiumCompany Announcements
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers
4M ago
STRO
Sutro Biopharma price target lowered to $3 from $4 at Wells Fargo
PremiumThe Fly
Sutro Biopharma price target lowered to $3 from $4 at Wells Fargo
5M ago
STRO
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase
PremiumRatings
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase
5M ago
STRO
Sutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results
PremiumCompany AnnouncementsSutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results
5M ago
STRO
Sutro Biopharma enters research collaboration with FDA for ADC standards
Premium
The Fly
Sutro Biopharma enters research collaboration with FDA for ADC standards
5M ago
STRO
Sutro Biopharma Faces NASDAQ Non-Compliance Notice
Premium
Company Announcements
Sutro Biopharma Faces NASDAQ Non-Compliance Notice
6M ago
8K
STRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >